Skip to Main Content

Yale SPORE in Lung Cancer

Yale SPORE in Lung Cancer

Yale School of MedicineYale Cancer Center
SPORE in Lung Cancer

About Us
Research Cores
Translational Projects
Funding Opportunities
News

Building a Powerhouse Team To Tackle Lung Cancer

Open the document

Yale SPORE in Lung Cancer News

March 02, 2021
Dr. Goldberg on the Toxicity Profile of Amivantamab in Metastatic EGFR Exon 20–Mutant NSCLC
Source: OneLive
Read more
December 18, 2020
Yale Study Leads to FDA Approval of Drug to Treat Non-small Cell Lung Cancer
Read more
October 07, 2020
Yale Cancer Center Researchers Report Results of Afatinib plus Cetuximab for Treatment of EGFR-Mutant NSCLC
Read more
October 01, 2020
Immunotherapy Drug Boosts Survival for Lung Cancer Patients
Source: U.S. News & World Report
Read more
October 01, 2020
Atezolizumab Appears Effective for Patients with NSCLC with High PD-L1 Expression
Source: Cancer Network
Read more

Maps & Directions
Calendar
Contact Us

Intranet
Site Editor
Accessibility at YSM
Terms & Privacy Policy
Yale University
Yale Phonebook

© 2021 Yale School of Medicine. Updated 08/13/2019

Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads